drugset / Trial / NCT02856685

A Study of Mitoxantrone Hydrochloride Liposome Infusion

NCT02856685

Phase 1/2 Unknown 60 enrolled CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

This is a Phase 1/2, open-label, multicenter study.

Timeline

Start
2016-08
Primary completion
2017-07
Completion
2018-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Mitoxantrone Small molecule Intravenous

Indications